220 related articles for article (PubMed ID: 144049)
1. Biochemical mechanisms and management of choreiform movement disorders.
de Silva L
Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049
[No Abstract] [Full Text] [Related]
2. Chorea.
Klawans HL
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):536-40. PubMed ID: 2445458
[TBL] [Abstract][Full Text] [Related]
3. [Physiology and pharmacology of extrapyramidal tract].
Yoshida M; Mizuno Y
Nihon Rinsho; 1975 Oct; 33(10):2964-77. PubMed ID: 128646
[No Abstract] [Full Text] [Related]
4. [Huntington chorea. Review of the most recent aspects of research].
Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
[TBL] [Abstract][Full Text] [Related]
5. Therapeutics of disordered movement.
Sears ES
Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
[TBL] [Abstract][Full Text] [Related]
6. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.
Fahn S; Libsch LR; Cutler RW
J Neurol Sci; 1971 Dec; 14(4):427-55. PubMed ID: 5125758
[No Abstract] [Full Text] [Related]
7. [Neurotransmitters in Huntington chorea (review)].
Barkhatova VP; Larskiĭ EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
[No Abstract] [Full Text] [Related]
8. Physostigmine in choreiform movement disorders.
Tarsy D; Leopold N; Sax DS
Neurology; 1974 Jan; 24(1):28-33. PubMed ID: 4358998
[No Abstract] [Full Text] [Related]
9. [Cholinergic and dopaminergic mechanisms in Huntingtons' chorea].
Aquilonius SM; Sjöström R
Nord Med; 1971 May; 85(21):675. PubMed ID: 4325716
[No Abstract] [Full Text] [Related]
10. Effect of tetrabenazine on extrapyramidal movement disorders.
Dalby MA
Br Med J; 1969 May; 2(5654):422-3. PubMed ID: 4238453
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced extrapyramidal disorders - a neuropsychiatric interface.
Goetz CG; Klawans HL
J Clin Psychopharmacol; 1981 Sep; 1(5):297-303. PubMed ID: 6120959
[TBL] [Abstract][Full Text] [Related]
12. Neurohumoral interactions and basal ganglia function and dysfunction.
Hornykiewicz O
Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
[No Abstract] [Full Text] [Related]
13. Rational approaches to the pharmacotherapy of chorea.
Chase TN
Res Publ Assoc Res Nerv Ment Dis; 1976; 55():337-50. PubMed ID: 137504
[No Abstract] [Full Text] [Related]
14. The pathogensis and medical treatment of extrapyramidal disease.
Calne DB; Eisler T
Med Clin North Am; 1979 Jul; 63(4):715-27. PubMed ID: 157413
[No Abstract] [Full Text] [Related]
15. Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
Klawans HL; Goetz C; Nausieda PA; Weiner WJ
Adv Exp Med Biol; 1977; 90():21-47. PubMed ID: 145167
[No Abstract] [Full Text] [Related]
16. Anatomical and biochemical basis of the extrapyramidal disorders.
Gauthier S; Sourkes TL
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):595-9. PubMed ID: 6131493
[TBL] [Abstract][Full Text] [Related]
17. Drugs and motor functions.
Gordon N
Dev Med Child Neurol; 1971 Jun; 13(3):384-6. PubMed ID: 4398415
[No Abstract] [Full Text] [Related]
18. Involuntary movement disorders.
Still CN
Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic mechanisms and extrapyramidal function in man.
Chase TN
Adv Neurol; 1974; 5():31-9. PubMed ID: 4280243
[No Abstract] [Full Text] [Related]
20. [Neuraminergic conception of extrapyramidal syndromology].
Levin SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):293-9. PubMed ID: 139066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
